Efficacy and toxicity of lower dose UFT without leucovorin in metastatic gastric cancer patients

---

Copy For Citation

Somali I., Meydan N., Tarhan M. O., Oztop I., Alacacioglu A., Yilmaz U.

JOURNAL OF BUON, vol.14, no.3, pp.429-433, 2009 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 14 Issue: 3
• Publication Date: 2009
• Journal Name: JOURNAL OF BUON
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.429-433
• Keywords: cisplatin, epirubicin, gastric cancer, metastatic, UFT, PHASE-II, 1ST-LINE CHEMOTHERAPY, COLORECTAL-CANCER, ORAL UFT, CISPLATIN, EPIRUBICIN, FLUOROURACIL, CARCINOMA, URACIL, TRIAL
• Dokuz Eylül University Affiliated: Yes

Abstract

Purpose: Gastric cancer is the 4th most commonly diagnosed cancer and the 2nd leading cause of cancer death worldwide. In this study assessed were the efficacy and toxicity of the combination of epirubicin, cisplatin and UFT in patients with metastatic gastric cancer (MGC).